` Comparison: CTABF vs DD - Alpha Spread

C
CTABF
vs
DD

Over the past 12 months, CTABF has underperformed DD, delivering a return of 0% compared to the DD's +43% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
CTABF
DD
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

C
CTABF Intrinsic Value
Not Available
DD Intrinsic Value
37.33 USD
Overvaluation 18%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
C
Canntab Therapeutics Ltd
OTC:CTABF
0.0001 USD
Dupont De Nemours Inc
NYSE:DD
45.62 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
CTABF, DD

CTABF
DD
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
C
Canntab Therapeutics Ltd
Revenue
Dupont De Nemours Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
CTABF, DD

CTABF
DD
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
C
Canntab Therapeutics Ltd
OTC:CTABF
Dupont De Nemours Inc
NYSE:DD
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

CTABF
-43.9%
DD
37.7%

Operating Margin

CTABF
-2 967.9%
DD
16.8%

Net Margin

CTABF
-4 565.3%
DD
-6.2%

FCF Margin

CTABF
-1 945%
DD
10.1%

ROE

CTABF
607.8%
DD
-3.3%

ROA

CTABF
-107.5%
DD
-2%

ROIC

CTABF
-102.1%
DD
-1.6%

ROCE

CTABF
-1 188.4%
DD
6.2%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
CTABF, DD

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
CTABF, DD

Loading
CTABF
DD
Difference
www.alphaspread.com

Performance By Year
CTABF, DD

Loading
CTABF
DD
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare CTABF to other stocks
Custom
Choose any stock to compare
Unlock Full Access to Alpha Spread
Create Free Account